January 2008 Issue of MMM
This time last year we boldly saluted Merck as MM&M's first All-Star Company of the Year.
When the going got tough, Merck got back to basics.
Uncommonly good creative has helped standalone agency AbelsonTaylor stand out among its peers, garner acclaim and earn loyalty from clients.
Eli Lilly & Co. spent $128 million promoting Cymbalta (duloxetene) for the year through August, according to IMS Health.
Since last year, when UCB, Inc. let users of its antiepileptic Keppra speak for the brand, patients have become an important visual and vocal component ...
With many of the industry's major blockbuster drugs coming off-patent in the next few years, pharmaceutical companies are scrambling to extend the life of their ...
In December we predicted a wild ride in 2008 for pharmaceutical marketing research.
In past columns I have defended the commonly used sleeping pill Ambien.
Funders of continuing medical education are becoming increasingly critical of satellite symposia.
On September 20, 2007, Sermo's founder and CEO Dr. Daniel Palestrant stepped up to the podium at the Health 2.0 conference in San Francisco and ...
Med Ed Report
Do physicians need a CNN for CME? Some vendors think so and are implementing real-time educational offerings.
The chairman of the House Committee on Oversight and Government Reform provoked industry exponents last month by leaking FDA draft guidance on off-label journal reprints.
Sermo launched its HotSpots feature, which contextually links to learning opportunities based on discussions taking place in the online physician community.
During an MM&M webcast, Pfizer's Bob Kristofco, MSW, said pharma "continues to have an expectation for more outcomes-oriented CME," and that he expects grants from ...
Melissa Warner has assumed the role of SVP and general manager of CME LLC.
Daniel Carlat, MD, vowed pro-bono visits to doctor's offices as a way to repay $30,000 he earned from paid lecturing.
In an editorial (Academic Medicine, Dec. 2007), Michael Whitcomb, MD, called producing a capable physician workforce "the most important challenge facing academic medicine."
Ascend Media is shedding its titles dependent on pharma ad revenue.
A would-be "YouTube for doctors" has posted 70 videos from Temple University.
Quadrant HealthCom launched Physicians' Travel & Meeting Network.
The Coalition for Healthcare Communication issued a statement in response to Rep. Henry Waxman's assault on pharmaceutical company's distribution of journal articles to doctors.
Wiley-Blackwell is relaunching its InfoPOEMs and InfoRetriever products under the name Essential Evidence Plus.
Many primary care journals have gotten dangerously thin this year, with some major medical publishers folding pharma ad revenue-dependent titles or putting them up for ...
As another new year rolls around, it's time to pull out the crystal ball and forecast how the Internet will evolve in 2008.
Revolution Health has acquired the online properties HealthTalk and SparkPeople in an attempt to challenge WebMD as the web's No. 1 health destination.
The future of e-marketing will be in focus from Jan. 28- Jan. 30 when the some of the top names in e-marketing gather at Philadelphia's ...
The District of Columbia could become the first jurisdiction within the country to require the licensing of pharmaceutical sales representatives, pending the outcome of a ...
Physicians were asked to rank the companies that have the best general sales reps, specialty sales reps, and medical science liaisons as part of "Specialty ...
Harte-Hanks has announced a series of changes and promotions as it enhances its digital practice area.
SK&A Information Services named Tim Powell senior director of sales, a newly created position.
Vincent Dean Boyce joins HealthEd as senior interactive designer.
MediZine announced the appointment of Sophia Tolstoy Penkrat as senior promotion manager.
Could DTC be going the way of detailing?
Writing in the December issue of Obstetrics & Gynecology, Dr. Erin Tracy said DTC ads for genetic tests are virtually unregulated and tests are costly ...
The European Commission drew fire from patient and public health advocacy groups for a public consultation on matters regarding regulation of the pharma industry.
Mr. Mucus is going to work for Reckitt Benckiser, which bought Adams Respiratory Therapeutics, maker of the heavily advertised Mucinex franchise, for $2.3 billion.
In an analyst call, Merck EVP and CFO Peter Kellogg said the company plans "continued DTC efforts for Singulair and Januvia as well as appropriate ...
The consumer has arrived in health.
Montel Williams, the talk-show host and spokesman for PhRMA's Partnership for Prescription Assistance, generated some unwelcome publicity when he lashed out at a 17-year-old intern ...
MWW Group named Ame Wadler EVP, chief management officer and global healthcare practice leader.
Market research departments of a number of life science companies incorporate analytics functions, either partially or fully, a study shows.
As pharma begins incorporating Web 2.0 tools in their marketing, many are unsure how to assess them.
Signs are everywhere that Washington is preparing for the next administration, whatever color it may be.
Former FDA deputy commissioner for medical and scientific affairs Scott Gottlieb, now a senior fellow at the American Enterprise Institute, has expressed serious concerns about ...
The FDA's newly staffed Risk Communication Advisory Committee will begin reviewing risk communication issues in the first quarter of 2008.
FDA review staffers have been subjected to so many requests to brief congressional staff members and supply documents that there is an "intimidating" atmosphere, according ...
State courts in West Virginia and New Jersey that declared the "learned intermediary" doctrine outmoded by DTC advertising were right on the money, according to ...
A bill to create a public registry of drug company gifts to physicians will be introduced in 2008 by Rep. Peter DeFazio (D-OR).
Responding to concerns about cough medicines labeled for children, Sen. Edward Kennedy (D-MA) and Rep. Henry Waxman (D-CA) have introduced the Non-Prescription Drug Modernization Act ...
The FDA plans to create and staff inspection offices throughout China and India, and possibly other countries.
January has kicked off the 2008 election cycle, with the Iowa caucuses and New Hampshire primaries taking the lead.
- Biogen ends Tecfidera DTC campaign, citing prescriptions
- As immuno-oncology therapies evolve, so will the marketing
- GSK Consumer Healthcare to prioritize digital after agency review
- Five things for pharma marketers to know: Thursday, July 21, 2016
- Five things for pharma marketers to know: Tuesday, July 26, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy
- 8 ways for pharma to improve the way it uses Twitter
- Five things for pharma marketers to know: Thursday, July 28, 2016
- Infographic: Type 2 diabetes, a country-by-country snapshot
- Moving Forward — Without the Promotion
- Sponsored Podcast: No Patient Left Behind: Connecting Rare Disease Patients to Orphan Drug Manufacturers